These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8857741)
1. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Pappert EJ; Tangney CC; Goetz CG; Ling ZD; Lipton JW; Stebbins GT; Carvey PM Neurology; 1996 Oct; 47(4):1037-42. PubMed ID: 8857741 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274 [TBL] [Abstract][Full Text] [Related]
3. Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group. Vatassery GT; Fahn S; Kuskowski MA Neurology; 1998 Jun; 50(6):1900-2. PubMed ID: 9633757 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: correlation with clinical profiles and neurochemistry. Mandybur GT; Miyagi Y; Yin W; Perkins E; Zhang JH Neurol Res; 2003 Jan; 25(1):104-11. PubMed ID: 12564136 [TBL] [Abstract][Full Text] [Related]
5. Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice. Xu MJ; Plezia PM; Alberts DS; Emerson SS; Peng YM; Sayers SM; Liu Y; Ritenbaugh C; Gensler HL J Natl Cancer Inst; 1992 Oct; 84(20):1559-65. PubMed ID: 1404449 [TBL] [Abstract][Full Text] [Related]
6. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562 [TBL] [Abstract][Full Text] [Related]
7. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. Winklhofer-Roob BM; van't Hof MA; Shmerling DH Am J Clin Nutr; 1996 May; 63(5):722-8. PubMed ID: 8615355 [TBL] [Abstract][Full Text] [Related]
8. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Shults CW; Flint Beal M; Song D; Fontaine D Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848 [TBL] [Abstract][Full Text] [Related]
9. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Hu JJ; Roush GC; Berwick M; Dubin N; Mahabir S; Chandiramani M; Boorstein R Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):263-70. PubMed ID: 8722217 [TBL] [Abstract][Full Text] [Related]
10. Vitamin E dose-response studies in humans with use of deuterated RRR-alpha-tocopherol. Traber MG; Rader D; Acuff RV; Ramakrishnan R; Brewer HB; Kayden HJ Am J Clin Nutr; 1998 Oct; 68(4):847-53. PubMed ID: 9771861 [TBL] [Abstract][Full Text] [Related]
11. Plasma tocopherol concentrations in response to supplemental vitamin E. Dimitrov NV; Meyer C; Gilliland D; Ruppenthal M; Chenoweth W; Malone W Am J Clin Nutr; 1991 Mar; 53(3):723-9. PubMed ID: 2000827 [TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Mogi M; Harada M; Narabayashi H; Inagaki H; Minami M; Nagatsu T Neurosci Lett; 1996 Jun; 211(1):13-6. PubMed ID: 8809836 [TBL] [Abstract][Full Text] [Related]
13. Cattle blood plasma and red blood cell alpha-tocopherol levels in response to different chemical forms and routes of administration of vitamin E. Roquet J; Nockels CF; Papas AM J Anim Sci; 1992 Aug; 70(8):2542-50. PubMed ID: 1506316 [TBL] [Abstract][Full Text] [Related]
14. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease. Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059 [TBL] [Abstract][Full Text] [Related]
15. Assessment of vitamin E concentrations in serum and cerebrospinal fluid of horses following oral administration of vitamin E. Higgins JK; Puschner B; Kass PH; Pusterla N Am J Vet Res; 2008 Jun; 69(6):785-90. PubMed ID: 18518659 [TBL] [Abstract][Full Text] [Related]
16. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals. Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354 [TBL] [Abstract][Full Text] [Related]
17. Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment. Tohgi H; Abe T; Saheki M; Hamato F; Sasaki K; Takahashi S Neurosci Lett; 1995 Jan; 184(1):21-4. PubMed ID: 7739798 [TBL] [Abstract][Full Text] [Related]
18. Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance. Hensley K; Barnes LL; Christov A; Tangney C; Honer WG; Schneider JA; Bennett DA; Morris MC J Alzheimers Dis; 2011; 24(4):767-74. PubMed ID: 21321395 [TBL] [Abstract][Full Text] [Related]
19. Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial. Lu L; Erhard P; Salomon RG; Weiss MF Am J Kidney Dis; 2007 Aug; 50(2):305-13. PubMed ID: 17660032 [TBL] [Abstract][Full Text] [Related]